New funding available to accelerate neuroscience projects
Thursday, March 22, 2012
HBI/AET Funding Announcement:
New funding available to accelerate neuroscience projects from the Hotchkiss Brain Institute (HBI) in collaboration with Alberta Advanced Education and Technology (AET) and The Centre for Drug Research and Development (CDRD) — Applications now being accepted
The Hotchkiss Brain Institute (HBI) is pleased to be working in partnership with Alberta Advanced Education and Technology (AET) and The Centre for Drug Research and Development (CDRD), a national Centre of Excellence for Commercialization and Research, to advance health research towards commercialization.
Through this joint initiative, investigators can now access drug development infrastructure, scientific and business expertise, and funding to move their breakthrough discoveries towards being developed into novel medicines. Funding for these drug development activities is provided via a new $400,000 Pre-Seed Technology Development Fund established by the HBI in collaboration with AET, which supplements additional funding already available through an existing partnership between CDRD and Pfizer.
With the goal to accelerate the commercialization of novel health technologies, these funds are collectively aimed at supporting promising drug development projects to the point where they may then form the basis for new company creation or a licensing opportunity — and ultimately be translated into high-value medicines to impact human health.
The HBI has engaged the services of Innovate Calgary, an experienced provider of commercialization and business incubation services, to manage the initial application process. Innovate Calgary will collect, assess and summarize the applications for reviews by the HBI, CDRD and Pfizer representatives.
Interested applicants are encouraged to apply through Innovate Calgary by completing the application form below and/or by contacting Chris Nicholls at email@example.com or 403-270-2426 by April 13, 2012.
For application form and criteria information please visit: innovatecalgary.com/data//1/rec_docs/326_HBI_AET.docx
The Hotchkiss Brain Institute at UCalgary, consists of more than 100 physicians and scientists who are dedicated to advancing neurological and mental health research and education. The Institute’s research strengths in foundational neuroscience (axon biology and regeneration, cerebral circulation, neural systems and behaviour) are leading to new treatments for neurological and psychiatric disorders, aimed at improving quality of life and patient care.
More information on the Hotchkiss Brain Institute can be found at www.hbi.ucalgary.ca.
About Innovate Calgary:
Innovate Calgary is a full service organization offering technology transfer and business incubator services to researchers, entrepreneurs and businesses within the advanced technology sector. Innovate Calgary supports commercialization by providing: business and technical advice, workshops, screening technologies for commercial potential, access to sector resources and networking events, licensing and intellectual property protection, company creation/incubation programs, and office and lab space including tenancy and business resources and facilities for technology companies. Innovate Calgary has evaluated over 1,600 discoveries, secured more than 600 patents and negotiated over 550 technology commercialization agreements in over 24 countries.
For additional information visit: www.innovatecalgary.com or call: 403-284-6400.
The Centre for Drug Research and Development (CDRD), a national Centre of Excellence for Commercialization and Research (CECR), is an independent not-for-profit public-private organization that provides drug development expertise and infrastructure to enable researchers from leading academic and health research institutions to advance promising, early-stage drug candidates. CDRD’s network of 20 affiliated research institutions across Canada represent billions invested in health-related research every year, and CDRD plays a pivotal role in translating that research into commercial products and economic returns including new jobs for Canada.
For additional information, visit: www.cdrd.ca or contact Dr. Kaley Wilson, Manager, Business Development via firstname.lastname@example.org.